Latest Loss Reporting News

Resouro Strategic Metals reports a $2.83 million loss for Q3 2025 while progressing its Tiros Titanium Dioxide and Rare Earth Elements Project, highlighted by an updated 1.9 billion tonne mineral resource estimate. The company also secured $3 million in a recent private placement, underpinning its exploration activities.

CD Private Equity Fund II reported a reduced net loss of $2.43 million for the half-year to September 2025, supported by $9.45 million in distributions from portfolio realisations. Despite foreign exchange headwinds, the Fund maintains a diversified portfolio and a positive long-term return track record.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Central Petroleum Limited has reported a robust 43% increase in underlying EBITDAX for FY2025, alongside its inaugural on-market share buy-back, signaling confidence in its strengthened financial footing and growth prospects.

Tolu Minerals Limited reported a $6.7 million loss for the half-year to June 2025, doubling last year’s deficit as it invests heavily in refurbishing the Tolukuma Gold Mine and expanding exploration. A recent $27.25 million capital raise aims to fund these ambitious development plans.

4DS Memory Limited posted a $9.68 million loss for FY2025 as it advanced its 20nm ReRAM technology, encountering manufacturing setbacks that prompted a detailed root cause analysis. The company secured $8 million in capital to support ongoing development and strategic partnerships.

Osteopore Limited reported a 6% increase in revenue to $1.56 million for the half-year ended June 2025, alongside a slight rise in net loss driven by expanded product development and compliance costs. The company secured key regulatory approvals and broadened its distribution footprint in Asia and the US.

Aeris Environmental Ltd reported a modest revenue increase for FY2025 but saw its operating loss widen sharply to $4.12 billion, raising concerns about its financial stability.

Elanor Investors Group reported a substantial $157.8 million net loss for FY24 amid asset devaluations and debt covenant breaches, prompting a strategic recapitalisation and leadership transition.

DigitalX Limited posted a larger loss for FY25 despite an 18% revenue increase, driven by digital asset appreciation and a bold Bitcoin accumulation strategy.

Adslot Ltd reported a 34% drop in revenue to $5.77 million for FY25 but significantly reduced its net loss by 65% to $3.7 million, driven by cost cuts and strategic partnerships. The company is focused on growing its Trading Technology segment despite ongoing market challenges.

Tryptamine Therapeutics reported a $5.33 million loss for FY25 while progressing key clinical trials of its psychedelic therapies and strengthening its leadership team. The company secured $6 million in funding and launched a world-first trial targeting Binge Eating Disorder.